Cited by 966IL-33, ST2, and ILC PathwaysCytokine Signaling Pathways and InteractionsGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Open access

Carriere, Virginie, Roussel, Lucie, Ortega, Nathalie, Lacorre, Delphine-Armelle, Americh, Laure, Aguilar, Luc, Bouche, Gérard, Girard, Jean-Philippe·2007·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.0606854104PMC PMC1765450

Open this paper in CoChat — free account

Abstract

Recent studies indicate that IL-1α functions intracellularly in pathways independent of its cell surface receptors by translocating to the nucleus and regulating transcription. Similarly, the chromatin-associated protein HMGB1 acts as both a nuclear factor and a secreted proinflammatory cytokine. Here, we show that IL-33, an IL-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, is an endothelium-derived, chromatin-associated nuclear factor with transcriptional repressor properties. We found that IL-33 is identical to NF-HEV, a nuclear factor preferentially expressed in high endothelial venules (HEV), that we previously characterized. Accordingly, in situ hybridization demonstrated that endothelial cells constitute a major source of IL-33 mRNA in chronically inflamed tissues from patients with rheumatoid arthritis and Crohn's disease. Immunostaining with three distinct antisera, directed against the N-terminal part and IL-1-like C-terminal domain, revealed that IL-33 is a heterochromatin-associated nuclear factor in HEV endothelial cells in vivo . Association of IL-33 with heterochromatin was also observed in human and mouse cells under living conditions. In addition, colocalization of IL-33 with mitotic chromatin was noted. Nuclear localization, heterochromatin-association, and targeting to mitotic chromosomes were all found to be mediated by an evolutionarily conserved homeodomain-like helix–turn–helix motif within the IL-33 N-terminal part. Finally, IL-33 was found to possess transcriptional repressor properties, associated with the homeodomain-like helix–turn–helix motif. Together, these data suggest that, similarly to IL1α and HMGB1, IL-33 is a dual function protein that may function as both a proinflammatory cytokine and an intracellular nuclear factor with transcriptional regulatory properties.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.0606854104

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
Schmitz, J., Owyang, A. M., Oldham, E. R., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,773
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L. V., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,386
Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,263
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
Lotze, M. T., & Tracey, K. J. (2005) · Nature reviews. Immunology · doi:10.1038/nri1594 · Cited by 2,490
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
Bonaldi, T., Talamo, F., Scaffidi, P., Ferrera, D., Porto, A., Bachi, A., Rubartelli, A., Agresti, A., & Bianchi, M. E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg516 · Cited by 1,252
Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin.
Brown, K., Guest, S. S., Smale, S., Hahm, K., Merkenschlager, M., & Fisher, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80472-9 · Cited by 824
HMG1 and 2, and related ‘architectural’ DNA-binding proteins
Thomas, J. O., & TRAVERS, A. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01801-1 · Cited by 619
Ikaros DNA-Binding Proteins Direct Formation of Chromatin Remodeling Complexes in Lymphocytes
Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80034-5 · Cited by 587

Show all 38 references

Research works printed but not linked: 1

CA Dinarello Eur Cytokine Netw 11, 483–486 (2000).

Sorted by citations

Items 201–300 of 965

Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis
Hong, Y.-O.-S., Moon, S.-J., Joo, Y.-B., Jeon, C., Cho, M., Ju, J., Oh, H., Heo, Y.-J., Park, S.-H., Kim, H.-Y., et al. (2011) · Journal of Korean medical science · doi:10.3346/jkms.2011.26.9.1132 · Cited by 127
IL-33 Exacerbates Autoantibody-Induced Arthritis
Xu, D., Jiang, H., Li, Y., Pushparaj, P. N., Kurowska‐Stolarska, M., Leung, B. P. L., Mu, R., Tay, H. K., McKenzie, A. N. J., McInnes, I. B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902685 · Cited by 122
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
Lopetuso, L. R., Salvo, C. D., Pastorelli, L., Rana, N., Senkfor, H. N., Petito, V., Martino, L. D., Scaldaferri, F., Gasbarrini, A., Cominelli, F., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803613115 · Cited by 121
Chromatin regulates IL-33 release and extracellular cytokine activity
Travers, J., Rochman, M., Miracle, C. E., Habel, J. E., Brusilovsky, M., Caldwell, J. M., Rymer, J. K., & Rothenberg, M. E. (2018) · Nature Communications · doi:10.1038/s41467-018-05485-x · Cited by 124
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
Manetti, M., Ibba‐Manneschi, L., Liakouli, V., Guiducci, S., Milia, A. F., Benelli, G., Marrelli, A., Conforti, M. L., Romano, E., Giacomelli, R., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119321 · Cited by 121
Acute Respiratory Barrier Disruption by Ozone Exposure in Mice
Sokołowska, M., Quesniaux, V. F. J., Akdiş, C. A., Chung, K. F., Ryffel, B., & Togbe, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02169 · Cited by 119
IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer’s Disease
Lau, S.-F., Chen, C., Fu, W.-Y., Qu, J. Y., Cheung, T. H., Fu, A. K. Y., & Ip, N. Y. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107530 · Cited by 114
IL-33 Raises Alarm
Lamkanfi, M., & Dixit, V. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.011 · Cited by 116
IL ‐33 is secreted by psoriatic keratinocytes and induces pro‐inflammatory cytokines via keratinocyte and mast cell activation
Balato, A., Lembo, S., Mattii, M., Schiattarella, M., Marino, R., de Paulis, A., Balato, N., & Ayala, F. (2012) · Experimental Dermatology · doi:10.1111/exd.12027 · Cited by 119
Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage
Scott, I. C., Majithiya, J. B., Sandén, C., Thornton, P., Sanders, P. N., Moore, T., Guscott, M. A., Corkill, D. J., Erjefalt, J. S., & Cohen, E. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21589-2 · Cited by 115
The Role of IL-33/ST2 Pathway in Tumorigenesis
Larsen, K. M., Minaya, M. K., Vaish, V., & Peña, M. M. O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092676 · Cited by 122
IL-33: A Novel Danger Signal System in Atopic Dermatitis
Cevikbas, F., & Steinhoff, M. S. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.66 · Cited by 118
IL-33 Activates B1 Cells and Exacerbates Contact Sensitivity
Komai‐Koma, M., Gilchrist, D. S., McKenzie, A. N. J., Goodyear, C. S., Xu, D., & Liew, F. Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002103 · Cited by 113
Transcriptional Regulation of Murine IL-33 by TLR and Non-TLR Agonists
Polumuri, S. K., Jayakar, G. G., Shirey, K. A., Roberts, Z. J., Perkins, D. J., Pitha, P. M., & Vogel, S. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1003554 · Cited by 112
Inherited mitochondrial DNA variants can affect complement, inflammation and apoptosis pathways: insights into mitochondrial-nuclear interactions
Kenney, M. C., Chwa, M., Atilano, S. R., Falatoonzadeh, P., Ramírez, C., Malik, D., Tarek, M., Cáceres‐del‐Carpio, J., Nesburn, A. B., Boyer, D. S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu065 · Cited by 112
IL-33 and the intestine: The good, the bad, and the inflammatory
Hodzic, Z., Schill, E. M., Bolock, A. M., & Good, M. L. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.017 · Cited by 110
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α–Mediated Bone Loss
Zaiss, M. M., Kurowska‐Stolarska, M., Böhm, C., Gary, R., Scholtysek, C., Stolarski, B., Reilly, J. H., Kerr, S. C., Millar, N. L., Kamradt, T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003487 · Cited by 114
Interleukin-33 in tumorigenesis, tumor immune evasion, and cancer immunotherapy
Lu, B., Yang, M., & Wang, Q. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1397-0 · Cited by 107
Biologics and the lung: TSLP and other epithelial cell-derived cytokines in asthma
Mitchell, P. D., & O’Byrne, P. M. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.06.009 · Cited by 113
Spinal IL-33/ST2 Signaling Contributes to Neuropathic Pain via Neuronal CaMKII–CREB and Astroglial JAK2–STAT3 Cascades in Mice
Liu, S., Mi, W., Li, Q., Zhang, M., Han, P., Hu, S., Mao‐Ying, Q., & Wang, Y.-Q. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000850 · Cited by 108
The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders
Saluja, R., Ketelaar, M. E., Hawro, T., Church, M. K., Maurer, M., & Nawijn, M. C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.018 · Cited by 110
Necroptosis directly induces the release of full‐length biologically active IL ‐33 in vitro and in an inflammatory disease model
Shlomovitz, I., Erlich, Z., Speir, M., Zargarian, S., Baram, N., Engler, M., Edry‐Botzer, L., Munitz, A., Croker, B. A., & Gerlic, M. (2018) · FEBS Journal · doi:10.1111/febs.14738 · Cited by 112
Effects of Panax ginseng on Tumor Necrosis Factor-α-Mediated Inflammation: A Mini-Review
Lee, D. C., & Lau, A. S. (2011) · Molecules · doi:10.3390/molecules16042802 · Cited by 108
ST2 and IL-33 in Pregnancy and Pre-Eclampsia
Granne, I., Southcombe, J. H., Snider, J., Tannetta, D., Child, T. J., Redman, C. W. G., & Sargent, I. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024463 · Cited by 107
Epithelium: the interplay between innate and Th2 immunity
Bulek, K., Swaidani, S., Aronica, M. A., & Li, X. (2010) · Immunology and Cell Biology · doi:10.1038/icb.2009.113 · Cited by 108
Mechanisms of IL-33 processing and secretion: differences and similarities between IL-1 family members
Lefrançais, E., & Cayrol, C. (2012) · European Cytokine Network · doi:10.1684/ecn.2012.0320 · Cited by 117
Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease
Seo, D. H., Che, X., Kwak, M. S., Kim, S., Kim, J. H., Ma, H. W., Kim, D. H., Kim, T. I., Kim, W. H., Kim, S. W., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00840-2 · Cited by 107
The Role of Airway Epithelial Cell Alarmins in Asthma
Whetstone, C. E., Ranjbar, M., Omer, H., Cusack, R. P., & Gauvreau, G. M. (2022) · Cells · doi:10.3390/cells11071105 · Cited by 114
Mast Cells Respond to Cell Injury through the Recognition of IL-33
Lunderius-Andersson, C., Enoksson, M., & Nilsson, G. P. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00082 · Cited by 109
Emerging role of interleukin‐33 in autoimmune diseases
Pei, C., Barbour, M., Fairlie‐Clarke, K. J., Allan, D., Mu, R., & Jiang, H. (2013) · Immunology · doi:10.1111/imm.12174 · Cited by 106
Serum IL-33 as a Diagnostic and Prognostic Marker in Non-small Cell Lung Cancer
Liang-an, H., Fu, Y., Zhang, D.-N., & Zhang, J. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2563 · Cited by 106
IL-33 attenuates development and perpetuation of chronic intestinal inflammation
Gro, P., Doser, K., Falk, W., Obermeier, F., & Hofmann, C. (2012) · Inflammatory Bowel Diseases · doi:10.1002/ibd.22900 · Cited by 109
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells
Oczypok, E. A., Milutinovic, P. S., Alcorn, J. F., Khare, A., Crum, L. T., Manni, M. L., Epperly, M. W., Pawluk, A. M., Ray, A., & Oury, T. D. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.03.011 · Cited by 105
IL-33/IL-31 Axis: A Potential Inflammatory Pathway
Salvo, E. D., Ventura-Spagnolo, E., Casciaro, M., Navarra, M., & Gangemi, S. (2018) · Mediators of Inflammation · doi:10.1155/2018/3858032 · Cited by 105
Interleukin‐33 in allergy
Ohno, T., Morita, H., Arae, K., Matsumoto, K., & Nakae, S. (2012) · Allergy · doi:10.1111/all.12004 · Cited by 110
Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation
Madouri, F., Guillou, N., Fauconnier, L., Marchiol, T., Rouxel, N., Chenuet, P., Ledru, A., Apétoh, L., Ghiringhelli, F., Chamaillard, M., et al. (2015) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjv012 · Cited by 106
Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion
Luzina, I. G., Pickering, E. M., Kopach, P., Kang, P. H., Lockatell, V., Todd, N. W., Papadimitriou, J. C., McKenzie, A. N. J., & Atamas, S. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200259 · Cited by 107
Reparative and Maladaptive Inflammation in Tendon Healing
Arvind, V., & Huang, A. H. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.719047 · Cited by 107
The enigmatic processing and secretion of interleukin-33
Zhao, W., & Hu, Z. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.3 · Cited by 103
IL-33: a Janus cytokine
Liew, F. Y. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200589 · Cited by 101
IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages
Yin, H., Li, X., Hu, S., Liu, T., Yuan, B., Gu, H., Ni, Q., Zhang, X., & Zheng, F. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.225 · Cited by 105
IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity
Cayrol, C. (2021) · Cells · doi:10.3390/cells11010107 · Cited by 104
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis
Talabot‐Ayer, D., McKee, T., Gindre, P., Bas, S., Baeten, D., Gabay, C., & Palmer, G. (2011) · Joint Bone Spine · doi:10.1016/j.jbspin.2011.02.011 · Cited by 103
Phenotypic and genetic aspects of epithelial barrier function in asthmatic patients
Loxham, M., & Davies, D. E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.005 · Cited by 104
The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis
Buckley, M. L., & Ramji, D. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.011 · Cited by 98
Contribution of IL-33 to induction and augmentation of experimental allergic conjunctivitis
松葉, 沙., Yoshimoto, T., Yasuda, K., Futatsugi‐Yumikura, S., Taki, Y., Muto, T., Ikeda, T., Mimura, O., & Nakanishi, K. (2010) · International Immunology · doi:10.1093/intimm/dxq035 · Cited by 99
Calycosin suppresses expression of pro-inflammatory cytokines via the activation of p62/Nrf2-linked heme oxygenase 1 in rheumatoid arthritis synovial fibroblasts
Su, X., Huang, Q., Chen, J., Wang, M., Pan, H., Wang, R., Zhou, H., Zhou, Z., Liu, J., Yang, F., et al. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.031 · Cited by 98
The Pro-tumorigenic IL-33 Involved in Antitumor Immunity: A Yin and Yang Cytokine
Fournié, J., & Poupot, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02506 · Cited by 99
Caspase 3 inactivates biologically active full length interleukin-33 as a classical cytokine but does not prohibit nuclear translocation
Ali, S., Nguyen, D. Q., Falk, W., & Martin, M. U. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.107 · Cited by 97
IL-33 and Airway Inflammation
Oboki, K., Nakae, S., Matsumoto, K., & Saito, H. (2011) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2011.3.2.81 · Cited by 100
IL ‐33/ ST 2 signalling contributes to carrageenin‐induced innate inflammation and inflammatory pain: role of cytokines, endothelin‐1 and prostaglandin E 2
Zarpelon, A., Cunha, T. M., Alves‐Filho, J., Pinto, L. G., Ferreira, S., McInnes, I. B., Xu, D., Liew, F. Y., Cunha, F. Q., & Verri, W. A., Jr. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12110 · Cited by 99
Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes
Mun, S. H., Ko, N. Y., Kim, H. S., Kim, J. W., Kim, D. K., Kim, A., Lee, S. H., Kim, Y., Lee, C. K., Lee, S. H., et al. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0410-y · Cited by 98
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Latiano, A., Palmieri, O., Pastorelli, L., Vecchi, M. L., Pizarro, T. T., Bossa, F., Merla, G., Augello, B., Latiano, T., Corritore, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062144 · Cited by 99
Genetic and genomic approaches to asthma
Zhang, Y., Moffatt, M. F., & Cookson, W. (2011) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834dc532 · Cited by 95
Activated mast cells synthesize and release soluble ST2‐a decoy receptor for IL‐33
Bandara, G., Beaven, M. A., Olivera, A., Gilfillan, A. M., & Metcalfe, D. D. (2015) · European Journal of Immunology · doi:10.1002/eji.201545501 · Cited by 99
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
Mertz, K. D., Mager, L. F., Wasmer, M.-H., Thiesler, T., Koelzer, V. H., Ruzzante, G., Joller, S., Murdoch, J. R., Brümmendorf, T., Genitsch, V., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1062966 · Cited by 98
Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population
Yang, Z., Liang, Y., Xi, W., Li, C., & Zhong, R. (2010) · Clinical and Experimental Medicine · doi:10.1007/s10238-010-0115-4 · Cited by 94
A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System
Long, H., Liao, W., Wang, L., & Lu, Q. (2016) · Transfusion Medicine and Hemotherapy · doi:10.1159/000445215 · Cited by 94
Interleukin 33: a switch-hitting cytokine
Villarreal, D. O., & Weiner, D. B. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.004 · Cited by 98
Amplification of cytokine production through synergistic activation of NFAT and AP‐1 following stimulation of mast cells with antigen and IL‐33
de Andrade, M. V. M., Iwaki, S., Ropert, C., Gazzinelli, R. T., Cunha-Melo, J. R., & Beaven, M. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201040718 · Cited by 93
Macrophage-Derived IL-33 Is a Critical Factor for Placental Growth
Fock, V., Mairhofer, M., Otti, G. R., Hiden, U., Spittler, A., Zeisler, H., Fiala, C., Knöfler, M., & Pollheimer, J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300490 · Cited by 96
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis
Lopetuso, L. R., Scaldaferri, F., & Pizarro, T. T. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-18 · Cited by 94
Extracellular IL-33 cytokine, but not endogenous nuclear IL-33, regulates protein expression in endothelial cells
Gautier, V., Cayrol, C., Farache, D., Roga, S., Monsarrat, B., Burlet‐Schiltz, O., de Peredo, A. G., & Girard, J. (2016) · Scientific Reports · doi:10.1038/srep34255 · Cited by 99
Self-citation
Interleukins and interleukin receptors in rheumatoid arthritis: Research, diagnostics and clinical implications
Magyari, L. (2014) · World Journal of Orthopedics · doi:10.5312/wjo.v5.i4.516 · Cited by 92
NLRP3 Inflammasome-Mediated Inflammation in Acute Pancreatitis
Ferrero-Andrés, A., Rosello, A. P., Roselló‐Catafau, J., & Folch‐Puy, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155386 · Cited by 98
Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
Takatori, H., Makita, S., Ito, T. K., Matsuki, A., & Nakajima, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02004 · Cited by 90
IL-33 Priming Regulates Multiple Steps of the Neutrophil-Mediated Anti-Candida albicans Response by Modulating TLR and Dectin-1 Signals
Le, H. T., Tran, V. G., Kim, W., Kim, J., Cho, H. R., & Kwon, B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103564 · Cited by 90
Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis
Mu, R., Huang, H., Li, Y., Li, C., Ye, H., & Li, Z. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100184 · Cited by 87
IL-33 and IL-18 in Inflammatory Bowel Disease Etiology and Microbial Interactions
Williams, M. A., O’Callaghan, A. A., & Corr, S. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01091 · Cited by 88
Microarray Analysis Identifies Changes in Inflammatory Gene Expression in Response to Amyloid-β Stimulation of Cultured Human Retinal Pigment Epithelial Cells
Kurji, K. H., Cui, J. Z., Lin, T. R., Harriman, D. I., Prasad, S. S., Kojic, L., & Matsubara, J. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3622 · Cited by 90
IL-33 and M2a Alveolar Macrophages Promote Lung Defense against the Atypical Fungal Pathogen Pneumocystis murina
Nelson, M. P., Christmann, B. S., Werner, J. L., Metz, A. E., Trevor, J. L., Lowell, C. A., & Steele, C. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002558 · Cited by 86
Interleukin-33: a novel mediator with a role in distinct disease pathologies
Kurowska‐Stolarska, M., Hueber, A. J., Stolarski, B., & McInnes, I. B. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02316.x · Cited by 92
Different Members of the IL-1 Family Come Out in Different Ways: DAMPs vs. Cytokines?
Carta, S., Lavieri, R., & Rubartelli, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00123 · Cited by 90
Dual functionality of interleukin‐1 family cytokines: implications for anti‐interleukin‐1 therapy
Luheshi, N., Rothwell, N. J., & Brough, D. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00331.x · Cited by 87
IL-33/ST2 axis in autoimmune disease
Shakerian, L., Kolahdooz, H., Garousi, M. T., Keyvani, V., Kheder, R. K., Faraj, T. A., Yazdanpanah, E., & Esmaeili, S. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156015 · Cited by 89
Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice
Zhiguang, X., Chen, W., Steven, R., Dong, W., Zhang, W., Mu, R., Zhanguo, L., & Zhang, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.04.005 · Cited by 85
Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children
Hamzaoui, A., Berraïes, A., Kaabachi, W., Maalmi, H., Ammar, J., & Hamzaoui, K. (2013) · Journal of Asthma · doi:10.3109/02770903.2013.816317 · Cited by 85
IL-33 Exacerbates Periodontal Disease through Induction of RANKL
Malcolm, J., Awang, R. A., Oliver-Bell, J., Butcher, J. P., Campbell, L., Planell, A. A., Lappin, D. F., Fukada, S. Y., Nile, C. J., Liew, F. Y., et al. (2015) · Journal of Dental Research · doi:10.1177/0022034515577815 · Cited by 84
Interleukin-33 in Asthma: How Big of a Role Does It Play?
Borish, L., & Steinke, J. W. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-010-0153-8 · Cited by 84
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Wasmer, M.-H., & Krebs, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00682 · Cited by 84
The Role of Interleukin-33 in Chronic Allergic Conjunctivitis
Matsuda, A., Okayama, Y., Terai, N., Yokoi, N., Ebihara, N., Tanioka, H., Kawasaki, S., Inatomi, T., Katoh, N., Ueda, E., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3365 · Cited by 84
Desirable cell death during anticancer chemotherapy
Locher, C., Conforti, R., Aymeric, L., Ma, Y., Yamazaki, T., Rusakiewicz, S., Tesnière, A., Ghiringhelli, F., Apétoh, L., Morel, Y., et al. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05763.x · Cited by 84
Self-citation
Interleukin-33 Increases Antibacterial Defense by Activation of Inducible Nitric Oxide Synthase in Skin
Li, C., Li, H., Jiang, Z., Zhang, T., Wang, Y., Li, Z., Wu, Y., Ji, S., Xiao, S., Ryffel, B., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003918 · Cited by 83
Nuclear expression of interleukin-33 in pancreatic stellate cells
Masamune, A., Watanabe, T., Kikuta, K., Satoh, K., Kanno, A., & Shimosegawa, T. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00178.2010 · Cited by 85
Mature interleukin-33 is produced by calpain-mediated cleavage in vivo
Hayakawa, M., Hayakawa, H., Matsuyama, Y., Tamemoto, H., Okazaki, H., & Tominaga, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.018 · Cited by 88
The complex cascade of cellular events governing inflammasome activation and IL-1β processing in response to inhaled particles
Rabolli, V., Lison, D., & Huaux, F. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0150-8 · Cited by 83
Role of IL‐38 and Its Related Cytokines in Inflammation
Yuan, X., Peng, X., Li, Y., & Li, M. (2015) · Mediators of Inflammation · doi:10.1155/2015/807976 · Cited by 83
Interleukin-33, friend and foe in type-2 immune responses
Hardman, C. S., & Ogg, G. S. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.004 · Cited by 83
IL‐33 attenuates the development of experimental autoimmune uveitis
Barbour, M., Allan, D., Xu, H., Pei, C., Chen, M., Niedbała, W., Fukada, S. Y., Besnard, A., Alves-Filho, J. C., Tong, X., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201444671 · Cited by 80
Special aspects of interleukin-33 and the IL-33 receptor complex
Martin, M. U. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.006 · Cited by 82
Interleukin-33: Its Emerging Role in Allergic Diseases
Ding, W., Zou, G.-L., Zhang, W. K., Lai, X., Chen, H.-W., & Xiong, L. (2018) · Molecules · doi:10.3390/molecules23071665 · Cited by 80
Melatonin attenuates carbon tetrachloride–induced liver fibrosis via inhibition of necroptosis
Choi, H., Kang, J., & Lee, S. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.002 · Cited by 79
Regulation of Inflammatory Cytokines for Spinal Cord Injury Repair Through Local Delivery of Therapeutic Agents
Ren, H., Chen, X., Tian, M., Zhou, J., Ouyang, H., & Zhang, Z. (2018) · Advanced Science · doi:10.1002/advs.201800529 · Cited by 76
Intracellular Interleukin-1α Mediates Interleukin-8 Production Induced by Chlamydia trachomatis Infection via a Mechanism Independent of Type I Interleukin-1 Receptor
Cheng, W., Shivshankar, P., Zhong, Y., Chen, D., Li, Z., & Zhong, G. (2007) · Infection and Immunity · doi:10.1128/iai.01313-07 · Cited by 78
IL-1 Family Antagonists in Mouse and Human Skin Inflammation
Martin, P., Goldstein, J. D., Mermoud, L., Díaz-Barreiro, A., & Palmer, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.652846 · Cited by 81
Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells
Schmieder, A., Multhoff, G., & Radons, J. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.286 · Cited by 77
IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis
Salvo, C. D., Wang, X.-M., Pastorelli, L., Mattioli, B., Omenetti, S., Buela, K.-A. G., Chowdhry, S., Garg, R. R., Goodman, W. A., Rodriguez‐Palacios, A., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.028 · Cited by 77
Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease
Bao, Y.-S., Na, S., Zhang, P., Jia, X., Liu, R., Yu, C., Mu, S.-H., & Xie, R. (2011) · Journal of Clinical Immunology · doi:10.1007/s10875-011-9622-7 · Cited by 76
Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formation in Vitro
Saleh, H., Eeles, D. G., Hodge, J. M., Nicholson, G. C., Gu, R., Pompolo, S., Gillespie, M. T., & Quinn, J. M. W. (2011) · Endocrinology · doi:10.1210/en.2010-1268 · Cited by 79
Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis
Xiangyang, Z., Lutian, Y., Zhao, L., Liping, X., Shen, H., & Lu, J. (2012) · Cytokine · doi:10.1016/j.cyto.2011.12.010 · Cited by 76

Authors: Carriere, V., Roussel, L., Ortega, N., Lacorre, D.-A., Americh, L., Aguilar, L., Bouche, G., & Girard, J.-P.
Affiliations: *Laboratoire de Biologie Vasculaire, Equipe Labellisée “La Ligue 2006,” Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089, 205 Route de Narbonne, 31077 Toulouse, France; and
Centre National de la Recherche Scientifique (FR)
Endocube, Prologue Biotech, BP700, Rue Pierre et Marie Curie, 31319 Labège Cedex, France
Corresponding author: Girard, Jean-Philippe
ORCID: Roussel, Lucie
Aguilar, Luc
Girard, Jean-Philippe
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2007-01-02
Volume: 104
Issue: 1
Pages: 282-287
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.0606854104
PMC: PMC1765450
OpenAlex: W2093396768
Cited by: 966
References: 38
Citations by year: 2026: 20 · 2025: 29 · 2024: 30 · 2023: 49 · 2022: 50 · 2021: 51 · 2020: 47 · 2019: 51 · 2018: 58 · 2017: 55 · 2016: 64 · 2015: 70 · 2014: 52 · 2013: 56 · 2012: 72
FWCI: 12.14
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Association pour la Recherche sur le Cancer
Drug Applied Research Center, Tabriz University of Medical Sciences
Topics: Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: IL-33, ST2 receptor, heterochromatin, nuclear factors, transcriptional repressor, endothelial cells, high endothelial venules, rheumatoid arthritis, Crohn's disease, chronic inflammation, HMGB1
MeSH terms: Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Animals, Arthritis, Rheumatoid, Crohn Disease, HeLa Cells, Heterochromatin, Humans, Interleukins, Membrane Proteins, Mitosis, Nuclear Proteins, Receptors, Cell Surface, Repressor Proteins, RNA, Messenger, 3T3 Cells, Conserved Sequence, Receptors, Interleukin, Nuclear Localization Signals, Amino Acid Motifs, Endothelial Cells, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks